|
Contents
|
|
|
|
Embryonal
Tumors
|
|
|
|
|
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R,
Milano GM, Garrè ML, Donfrancesco A
A
multimodal strategy based on surgery, radiotherapy, ICE regimen and high
dose chemotherapy in atypical teratoid/rhabdoid tumours: a single
institution experience
J Neurooncol.
2009 Apr;92(2):177-83. Epub 2008 Nov 29
.JPG)
Abstract
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53
|
|
|
Gliofibroma
|
|
|
|
C.
R. Suarez, S. J. Bertolone
Carboplatinum
(CBDCA), vincristine (V) therapy for CNS gliofibroma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 461
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U, Huang
A, Bouffet E
Weekly vinblastine in pediatric low-grade glioma patients
with carboplatin allergic reaction
Cancer.
2005 Apr 28; [Epub ahead of print]
|
|
|
Ronghe
M, Hargrave D, Bartels U, Tabori U, Vaidya S, Chandler C, Kulkarni A,
Bouffet E.
Vincristine and carboplatin chemotherapy for unresectable and/or recurrent
low-grade astrocytoma of the brainstem
Pediatr Blood Cancer. 2010 May 26;. [Epub ahead of print]
Abstract
|
|
Sridharan Gururangan, Christina
M. Cavazos, David Ashley, James E. Herndon, II,
Carol S. Bruggers, Albert Moghrabi, Deborah
L. Scarcella, Melody Watral, Sandra Tourt-Uhlig,
David Reardon, Henry S. Friedman
Phase II Study of Carboplatin
in Children With Progressive Low-Grade Gliomas
.
(Abstract+)
|
|
|
Medulloblastoma
|
|
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
479
|
|
|
Metastatic
Tumors
|
|
|
|
D. Y. Kim, K. W. Lee, T. Yun,
J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of
platinum-based chemotherapy after cranial irradiation in patients with brain
metastasis from non-small cell lung cancer
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004
|
|
Robert
Morgan Jr., Timothy Synold, Adam Mamelak, Kim Margolin, Al-Kadhimi Zaid,
Przemyslaw Twardowski, Lucille Leong, Dean Lim, Sandeep Reddy, Isan Chen, Warren
Chow, Stephen Shibata, George Somlo, Yun Yen, Paul Frankel, James H Doroshow
Phase
I trial of tamoxifen (Tam), carboplatin (C), and topotecan (T) in recurrent or
metastatic brain tumors
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2102
|
|
|
Oligod.
T. & Mixed Gliomas
|
|
|
|
U.
Basso, F. Vastola, L. M. Pasetto, A. Scola, M. Ermani, M. Cacciacarne, F.
Sala, A. Talacchi, M. K. Paris, A. A. Brandes
Carboplatin
and VM-26 as third-line chemotherapy in patients with oligodendroglioma
refractory to PCV and temozolomide
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 433
|
|
A. A. Brandes, U. Basso, F. Vastola, A. Tosoni, L. M. Pasetto, A. Jirillo,
S. Lonardi, M. K. Paris, H. Koussis, S. Monfardini and M. Ermani
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent
oligodendroglioma or oligoastrocytoma: a phase II study
Annals
of Oncology 14:1727-1731, December 2003
|
|
L. Scopece, G. Cavallo, E.
Palmerini, E. Franceschi, A. Paioli, F. Spagnolli, S. Rimondini, R. Conforti, R.
Degli Esposti, L. Crino
Carboplatin and etoposide (CE) chemotherapy in
patients with recurrent or progressive oligodendroglial tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1562
|
|
Soffietti R, Nobile M, Ruda R, Borgognone M, Costanza A,
Laguzzi E, Mutani R
Second-line treatment with carboplatin for
recurrent or progressive oligodendroglial tumors after PCV (procarbazine,
lomustine, and vincristine) chemotherapy: a phase II study
Cancer. 2004 Feb 15;100(4):807-13
|
|
